Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses

Journal of Experimental Medicine

Volumn 203, Issue 3, 2006, Pages 599-606

  Boscardin, Silvia B ^a   Hafalla, Julius C R ^b   Masilamani, Revati F ^a   Kamphorst, Alice O ^a   Zebroski, Henry A ^a   Rai, Urvashi ^b   Morrot, Alexandre ^c   Zavala, Fidel ^c   Steinman, Ralph M ^a   Nussenzweig, Ruth S ^b   Nussenzweig, Michel C ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ANTIGEN; CARRIER PROTEIN; CIRCUMSPOROZOITE PROTEIN; HAPTEN ANTIBODY; HELPER FACTOR; IMMUNOGLOBULIN G; OVALBUMIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; CELL MATURATION; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; HUMORAL IMMUNITY; IMMUNIZATION; LYMPHOID ORGAN; MOUSE; NONHUMAN; PLASMODIUM YOELII; PRIORITY JOURNAL; STIMULUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TITRIMETRY;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; ANTIBODY FORMATION; ANTIGEN PRESENTATION; B-LYMPHOCYTES; CHICKENS; DENDRITIC CELLS; HAPTENS; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED BALB C; OVALBUMIN; PLASMODIUM YOELII; PROTOZOAN PROTEINS; T-LYMPHOCYTES;

EID: 33645087653     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20051639     Document Type: Article

References (42)

1. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
2. Lanzavecchia, A., and F. Sallusto. 2001. Regulation of T cell immunity by dendritic cells. Cell. 106:263-266.
3. Liu, Y.J. 2001. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell. 106:259-262.
4. Guermonprez, P., J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621-667.
5. Steinman, R.M., and M.D. Witmer. 1978. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. USA. 75:5132-5136.
6. Nussenzweig, M.C., R.M. Steinman, B. Gutchinov, and Z.A. Cohn. 1980. Dendritic cells are accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes. J. Exp. Med. 152:1070-1084.
7. Van Voorhis, W.C., J. Valinsky, E. Hoffman, J. Luban, L.S. Hair, and R.M. Steinman. 1983. Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication. J. Exp. Med. 158:174-191.
8. Inaba, K., and R.M. Steinman. 1985. Protein-specific helper T-lymphocyte formation initiated by dendritic cells. Science. 229:475-479.
9. Banchereau, J., and A.K. Palucka. 2005. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5:296-306.
10. Pulendran, B. 2004. Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol. Rev. 199:227-250.
11. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J.V. Ravetch, R.M. Steinman, and M.C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769-779.
12. + T cell tolerance. J. Exp. Med. 196:1627-1638.
13. Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M.C. Nussenzweig, and H. von Boehmer. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. In press.
14. Hawiger, D., R.F. Masilamani, E. Bettelli, V.K. Kuchroo, and M.C. Nussenzweig. 2004. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity. 20:695-705.
15. van Kooten, C., and J. Banchereau. 1997. Functions of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9:330-337.
16. Bonifaz, L.C., D.P. Bonnyay, A. Charalambous, D.I. Darguste, S. Fujii, H. Soares, M.K. Brimnes, B. Moltedo, T.M. Moran, and R.M. Steinman. 2004. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199:815-824.
17. Steinman, R.M., and M.C. Nussenzweig. 2002. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA. 99:351-358.
18. Steinman, R.M., and M. Pope. 2002. Exploiting dendritic cells to improve vaccine efficacy. J. Clin. Invest. 109:1519-1526.
19. Paul, W.E., G.W. Siskind, and B. Benacerraf. 1966. Studies on the effect of the carrier molecule on antihapten antibody synthesis. II. Carrier specificity of anti-2,4-dinitrophenyl-poly-l-lysine antibodies. J. Exp. Med. 123:689-705.
20. Rajewsky, K., V. Schirrmacher, S. Nase, and N.K. Jerne. 1969. The requirement of more than one antigenic determinant for immunogenicity. J. Exp. Med. 129:1131-1143.
21. Katz, D.H., W.E. Paul, E.A. Goidl, and B. Benacerraf. 1970. Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization. J. Exp. Med. 132:261-282.
22. Mitchison, N.A. 1971. The carrier effect in the secondary response to hapten-protein conjugates. I. Measurement of the effect with transferred cells and objections to the local environment hypothesis. Eur. J. Immunol. 1:10-17.
23. Reth, M., G.J. Hammerling, and K. Rajewsky. 1978. Analysis of the repertoire of anti-NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response. Eur. J. Immunol. 8:393-400.
24. Zavala, F., J.P. Tam, P.J. Barr, P.J. Romero, V. Ley, R.S. Nussenzweig, and V. Nussenzweig. 1987. Synthetic peptide vaccine confers protection against murine malaria. J. Exp. Med. 166:1591-1596.
25. Rodrigues, M., S. Li, K. Murata, D. Rodriguez, J.R. Rodriguez, I. Bacik, J.R. Bennink, J.W. Yewdell, A. Garcia-Sastre, R.S. Nussenzweig, et al. 1994. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity. J. Immunol. 153:4636-4648.
26. Stoute, J.A., M. Slaoui, D.G. Heppner, P. Momin, K.E. Kester, P. Desmons, B.T. Wellde, N. Garcon, U. Krzych, and M. Marchand. 1997. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. N. Engl. J. Med. 336:86-91.
27. Nardin, E.H., G.A. Oliveira, J.M. Calvo-Calle, K. Wetzel, C. Maier, A.J. Birkett, P. Sarpotdar, M.L. Corado, G.B. Thornton, and A. Schmidt. 2004. Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes. Infect. Immun. 72:6519-6527.
28. + T cells against malaria liver stages. J. Exp. Med. 194:173-180.
29. Grillot, D., M. Michel, I. Muller, C. Tougne, L. Renia, D. Mazier, G. Corradin, P.H. Lambert, J.A. Louis, and G. Del Guidice. 1990. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii. Eur. J. Immunol. 20:1215-1222.
30. Takita-Sonoda, Y., M. Tsuji, K. Kamboj, R.S. Nussenzweig, P. Clavijo, and F. Zavala. 1996. Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein. Exp. Parasitol. 84:223-230.
31. Rodrigues, M.M., A.S. Cordey, G. Arreaza, G. Corradin, P. Romero, J.L. Maryanski, R.S. Nussenzweig, and F. Zavala. 1991. CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int. Immunol. 3:579-585.
32. Lal, A.A., V.F. de la Cruz, J.A. Welsh, Y. Charoenvit, W.L. Maloy, and T.F. McCutchan. 1987. Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. A rodent model for examining antimalarial sporozoite vaccines. J. Biol. Chem. 262:2937-2940.
33. Liu, Y.J., J. Zhang, P.J. Lane, E.Y. Chan, and I.C. MacLennan. 1991. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur. J. Immunol. 21:2951-2962.
34. Jacob, J., C. Miller, and G. Kelsoe. 1992. In situ studies of the antigen-driven somatic hypermutation of immunoglobulin genes. Immunol. Cell Biol. 70:145-152.
35. Rajewsky, K. 1996. Clonal selection and learning in the antibody system. Nature. 381:751-758.
36. Stavnezer, J. 2000. Molecular processes that regulate class switching. Curr. Top. Microbiol. Immunol. 245:127-168.
37. Purtscher, M., A. Trkola, G. Gruber, A. Buchacher, R. Predl, F. Steindl, C. Tauer, R. Berger, N. Barrett, A. Jungbauer, et al. 1994. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses. 10:1651-1658.
38. Trkola, A., A.B. Pomales, H. Yuan, B. Korber, P.J. Maddon, G.P. Allaway, H. Katinger, C.F. Barbas III, D.R. Burton, D.D. Ho, et al. 1995. Cross-clade neutralization of primary isolates of human immunodefi ciency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J. Virol. 69:6609-6617.
39. Stiegler, G., R. Kunert, M. Purtscher, S. Wolbank, R. Voglauer, F. Steindl, and H. Katinger. 2001. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses. 17:1757-1765.
40. Yoshida, N., R.S. Nussenzweig, P. Potocnjak, V. Nussenzweig, and M. Aikawa. 1980. Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science. 207:71-73.
41. Charoenvit, Y., W.E. Collins, T.R. Jones, P. Millet, L. Yuan, G.H. Campbell, R.L. Beaudoin, J.R. Broderson, and S.L. Hoffman. 1991. Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science. 251:668-671.
42. Charoenvit, Y., S. Mellouk, C. Cole, R. Bechara, M.F. Leef, M. Sedegah, L.F. Yuan, F.A. Robey, R.L. Beaudoin, and S.L. Hoffman. 1991. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites. J. Immunol. 146:1020-1025.